Sox2+ stem/progenitor cells in the adult mouse pituitary support organ homeostasis and have tumor-inducing potential

Cell Stem Cell

Volumn 13, Issue 4, 2013, Pages 433-445

  Andoniadou, Cynthia Lilian ^a   Matsushima, Danielle ^b   Mousavy Gharavy, Seyedeh Neda ^a   Signore, Massimo ^a   Mackintosh, Albert Ian ^a   Schaeffer, Marie ^c,d   Gaston Massuet, Carles ^a   Mollard, Patrice ^c,d   Jacques, Thomas Stanley ^a,e   Le Tissier, Paul ^a   Dattani, Mehul Tulsidas ^e   Pevny, Larysa Halyna ^b   Martinez Barbera, Juan Pedro ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c INSTITUT DE GÉNOMIQUE FONCTIONNELLE   (France)

^d UNIV MONTPELLIER   (France)

^e GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR SOX2; SOX2 PROTEIN, MOUSE; TRANSCRIPTION FACTOR SOX;

ADULT STEM CELL; ANIMAL CELL; ARTICLE; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CELL LINEAGE; CONTROLLED STUDY; EMBRYO; EMBRYO DEVELOPMENT; EMBRYONIC STEM CELL; HOMEOSTASIS; HYPOPHYSIS CELL; HYPOPHYSIS TUMOR; IN VIVO STUDY; MOUSE; NONHUMAN; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR VOLUME; ANIMAL; CELL CULTURE; CYTOLOGY; GENETICS; HYPOPHYSIS; METABOLISM; MUTATION; PATHOLOGY; STEM CELL; TRANSGENIC MOUSE;

ANIMALS; CELLS, CULTURED; HOMEOSTASIS; MICE; MICE, TRANSGENIC; MUTATION; PITUITARY GLAND; PITUITARY NEOPLASMS; SOXB1 TRANSCRIPTION FACTORS; STEM CELLS;

EID: 84885133119     PISSN: 19345909     EISSN: 18759777     Source Type: Journal    
DOI: 10.1016/j.stem.2013.07.004     Document Type: Article

References (66)

1. K.S. Alatzoglou, C.L. Andoniadou, D. Kelberman, C.R. Buchanan, J. Crolla, M.C. Arriazu, M. Roubicek, D. Moncet, J.P. Martinez-Barbera, and M.T. Dattani SOX2 haploinsufficiency is associated with slow progressing hypothalamo- pituitary tumours Hum. Mutat. 32 2011 1376 1380
2. S. Alcantara Llaguno, J. Chen, C.H. Kwon, E.L. Jackson, Y. Li, D.K. Burns, A. Alvarez-Buylla, and L.F. Parada Malignant astrocytomas originate from neural stem/progenitor cells in a somatic tumor suppressor mouse model Cancer Cell 15 2009 45 56
3. W. Allaerts, P. Carmeliet, and C. Denef New perspectives in the function of pituitary folliculo-stellate cells Mol. Cell. Endocrinol. 71 1990 73 81
4. C.L. Andoniadou, M. Signore, E. Sajedi, C. Gaston-Massuet, D. Kelberman, A.J. Burns, N. Itasaki, M. Dattani, and J.P. Martinez-Barbera Lack of the murine homeobox gene Hesx1 leads to a posterior transformation of the anterior forebrain Development 134 2007 1499 1508
5. C.L. Andoniadou, C. Gaston-Massuet, R. Reddy, R.P. Schneider, M.A. Blasco, P. Le Tissier, T.S. Jacques, L.H. Pevny, M.T. Dattani, and J.P. Martinez-Barbera Identification of novel pathways involved in the pathogenesis of human adamantinomatous craniopharyngioma Acta Neuropathol. 124 2012 259 271
6. K. Arnold, A. Sarkar, M.A. Yram, J.M. Polo, R. Bronson, S. Sengupta, M. Seandel, N. Geijsen, and K. Hochedlinger Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice Cell Stem Cell 9 2011 317 329
7. N. Barker, R.A. Ridgway, J.H. van Es, M. van de Wetering, H. Begthel, M. van den Born, E. Danenberg, A.R. Clarke, O.J. Sansom, and H. Clevers Crypt stem cells as the cells-of-origin of intestinal cancer Nature 457 2009 608 611
8. N. Barker, A. van Oudenaarden, and H. Clevers Identifying the stem cell of the intestinal crypt: strategies and pitfalls Cell Stem Cell 11 2012 452 460
9. S. Bilodeau, A. Roussel-Gervais, and J. Drouin Distinct developmental roles of cell cycle inhibitors p57Kip2 and p27Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells Mol. Cell. Biol. 29 2009 1895 1908
10. S. Borson, G. Schatteman, P. Claude, and M. Bothwell Neurotrophins in the developing and adult primate adenohypophysis: a new pituitary hormone system? Neuroendocrinology 59 1994 466 476
11. R. Buslei, M. Nolde, B. Hofmann, S. Meissner, I.Y. Eyupoglu, F. Siebzehnrübl, E. Hahnen, J. Kreutzer, and R. Fahlbusch Common mutations of beta-catenin in adamantinomatous craniopharyngiomas but not in other tumours originating from the sellar region Acta Neuropathol. 109 2005 589 597
12. E. Carbajo-Pérez, and Y.G. Watanabe Cellular proliferation in the anterior pituitary of the rat during the postnatal period Cell Tissue Res. 261 1990 333 338
13. F. Castinetti, S.W. Davis, T. Brue, and S.A. Camper Pituitary stem cell update and potential implications for treating hypopituitarism Endocr. Rev. 32 2011 453 471
14. J. Chen, Y. Li, T.S. Yu, R.M. McKay, D.K. Burns, S.G. Kernie, and L.F. Parada A restricted cell population propagates glioblastoma growth after chemotherapy Nature 488 2012 522 526
15. S.W. Davis, A.H. Mortensen, and S.A. Camper Birthdating studies reshape models for pituitary gland cell specification Dev. Biol. 352 2011 215 227
16. S. Devnath, and K. Inoue An insight to pituitary folliculo-stellate cells J. Neuroendocrinol. 20 2008 687 691
17. G. Driessens, B. Beck, A. Caauwe, B.D. Simons, and C. Blanpain Defining the mode of tumour growth by clonal analysis Nature 488 2012 527 530
18. D. Dworakowska, and A.B. Grossman The molecular pathogenesis of pituitary tumors: implications for clinical management Minerva Endocrinol. 37 2012 157 172
19. P. Ellis, B.M. Fagan, S.T. Magness, S. Hutton, O. Taranova, S. Hayashi, A. McMahon, M. Rao, and L. Pevny SOX2, a persistent marker for multipotential neural stem cells derived from embryonic stem cells, the embryo or the adult Dev. Neurosci. 26 2004 148 165
20. T. Fauquier, K. Rizzoti, M. Dattani, R. Lovell-Badge, and I.C. Robinson SOX2-expressing progenitor cells generate all of the major cell types in the adult mouse pituitary gland Proc. Natl. Acad. Sci. USA 105 2008 2907 2912
21. T. Florio Adult pituitary stem cells: from pituitary plasticity to adenoma development Neuroendocrinology 94 2011 265 277
22. Q. Fu, and H. Vankelecom Regenerative capacity of the adult pituitary: multiple mechanisms of lactotrope restoration after transgenic ablation Stem Cells Dev. 21 2012 3245 3257
23. Q. Fu, L. Gremeaux, R.M. Luque, D. Liekens, J. Chen, T. Buch, A. Waisman, R. Kineman, and H. Vankelecom The adult pituitary shows stem/progenitor cell activation in response to injury and is capable of regeneration Endocrinology 153 2012 3224 3235
24. M. Garcia-Lavandeira, V. Quereda, I. Flores, C. Saez, E. Diaz-Rodriguez, M.A. Japon, A.K. Ryan, M.A. Blasco, C. Dieguez, M. Malumbres, and C.V. Alvarez A GRFa2/Prop1/stem (GPS) cell niche in the pituitary PLoS ONE 4 2009 e4815
25. C. Gaston-Massuet, C.L. Andoniadou, M. Signore, S.A. Jayakody, N. Charolidi, R. Kyeyune, B. Vernay, T.S. Jacques, M.M. Taketo, and P. Le Tissier Increased Wingless (Wnt) signaling in pituitary progenitor/stem cells gives rise to pituitary tumors in mice and humans Proc. Natl. Acad. Sci. USA 108 2011 11482 11487
26. S.Y. Gidekel Friedlander, G.C. Chu, E.L. Snyder, N. Girnius, G. Dibelius, D. Crowley, E. Vasile, R.A. DePinho, and T. Jacks Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras Cancer Cell 16 2009 379 389
27. A.S. Gleiberman, T. Michurina, J.M. Encinas, J.L. Roig, P. Krasnov, F. Balordi, G. Fishell, M.G. Rosenfeld, and G. Enikolopov Genetic approaches identify adult pituitary stem cells Proc. Natl. Acad. Sci. USA 105 2008 6332 6337
28. L. Gremeaux, Q. Fu, J. Chen, and H. Vankelecom Activated phenotype of the pituitary stem/progenitor cell compartment during the early-postnatal maturation phase of the gland Stem Cells Dev. 21 2012 801 813
29. M. Gueorguiev, and A.B. Grossman Pituitary tumors in 2010: a new therapeutic era for pituitary tumors Nat. Rev. Endocrinol. 7 2011 71 73
30. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 2011 646 674
31. N. Harada, Y. Tamai, T. Ishikawa, B. Sauer, K. Takaku, M. Oshima, and M.M. Taketo Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene EMBO J. 18 1999 5931 5942
32. B.M. Hofmann, J. Kreutzer, W. Saeger, M. Buchfelder, I. Blümcke, R. Fahlbusch, and R. Buslei Nuclear beta-catenin accumulation as reliable marker for the differentiation between cystic craniopharyngiomas and rathke cleft cysts: a clinico-pathologic approach Am. J. Surg. Pathol. 30 2006 1595 1603
33. T.S. Jacques, A. Swales, M.J. Brzozowski, N.V. Henriquez, J.M. Linehan, Z. Mirzadeh, C. O'Malley, H. Naumann, A. Alvarez-Buylla, and S. Brandner Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes EMBO J. 29 2010 222 235
34. S.A. Jayakody, C.L. Andoniadou, C. Gaston-Massuet, M. Signore, A. Cariboni, P.M. Bouloux, P. Le Tissier, L.H. Pevny, M.T. Dattani, and J.P. Martinez-Barbera SOX2 regulates the hypothalamic-pituitary axis at multiple levels J. Clin. Invest. 122 2012 3635 3646
35. E.H. Jho, T. Zhang, C. Domon, C.K. Joo, J.N. Freund, and F. Costantini Wnt/beta-catenin/Tcf signaling induces the transcription of Axin2, a negative regulator of the signaling pathway Mol. Cell. Biol. 22 2002 1172 1183
36. D. Kelberman, K. Rizzoti, R. Lovell-Badge, I.C. Robinson, and M.T. Dattani Genetic regulation of pituitary gland development in human and mouse Endocr. Rev. 30 2009 790 829
37. M. Labeur, M. Páez-Pereda, M. Haedo, E. Arzt, and G.K. Stalla Pituitary tumors: cell type-specific roles for BMP-4 Mol. Cell. Endocrinol. 326 2010 85 88
38. J.D. Lathia, J.M. Heddleston, M. Venere, and J.N. Rich Deadly teamwork: neural cancer stem cells and the tumor microenvironment Cell Stem Cell 8 2011 482 485
39. A. Levy Physiological implications of pituitary trophic activity J. Endocrinol. 174 2002 147 155
40. A. Levy Stem cells, hormones and pituitary adenomas J. Neuroendocrinol. 20 2008 139 140
41. S. Li, E.B. Crenshaw 3rd, E.J. Rawson, D.M. Simmons, L.W. Swanson, and M.G. Rosenfeld Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene pit-1 Nature 347 1990 528 533
42. A. Lujambio, L. Akkari, J. Simon, D. Grace, D.F. Tschaharganeh, J.E. Bolden, Z. Zhao, V. Thapar, J.A. Joyce, V. Krizhanovsky, and S.W. Lowe Non-cell-autonomous tumor suppression by p53 Cell 153 2013 449 460
43. S. Melmed Pathogenesis of pituitary tumors Nat. Rev. Endocrinol. 7 2011 257 266
44. P. Mollard, D.J. Hodson, C. Lafont, K. Rizzoti, and J. Drouin A tridimensional view of pituitary development and function Trends Endocrinol. Metab. 23 2012 261 269
45. D.J. Mulholland, L. Xin, A. Morim, D. Lawson, O. Witte, and H. Wu Lin-Sca-1+CD49fhigh stem/progenitors are tumor-initiating cells in the Pten-null prostate cancer model Cancer Res. 69 2009 8555 8562
46. H.L. Müller Childhood craniopharyngioma - current concepts in diagnosis, therapy and follow-up Nat. Rev. Endocrinol. 6 2010 609 618
47. L.V. Nguyen, R. Vanner, P. Dirks, and C.J. Eaves Cancer stem cells: an evolving concept Nat. Rev. Cancer 12 2012 133 143
48. N. Oshimori, and E. Fuchs Paracrine TGF-β signaling counterbalances BMP-mediated repression in hair follicle stem cell activation Cell Stem Cell 10 2012 63 75
49. L. Pevny, and M.S. Rao The stem-cell menagerie Trends Neurosci. 26 2003 351 359
50. T. Reya, and H. Clevers Wnt signalling in stem cells and cancer Nature 434 2005 843 850
51. J.M. Rosen, and C.T. Jordan The increasing complexity of the cancer stem cell paradigm Science 324 2009 1670 1673
52. A. Sarkar, and K. Hochedlinger The sox family of transcription factors: versatile regulators of stem and progenitor cell fate Cell Stem Cell 12 2013 15 30
53. A.G. Schepers, H.J. Snippert, D.E. Stange, M. van den Born, J.H. van Es, M. van de Wetering, and H. Clevers Lineage tracing reveals Lgr5+ stem cell activity in mouse intestinal adenomas Science 337 2012 730 735
54. S. Srinivas, T. Watanabe, C.S. Lin, C.M. William, Y. Tanabe, T.M. Jessell, and F. Costantini Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus BMC Dev. Biol. 1 2001 4
55. R. Sutter, O. Shakhova, H. Bhagat, H. Behesti, C. Sutter, S. Penkar, A. Santuccione, R. Bernays, F.L. Heppner, and U. Schüller Cerebellar stem cells act as medulloblastoma-initiating cells in a mouse model and a neural stem cell signature characterizes a subset of human medulloblastomas Oncogene 29 2010 1845 1856
56. Y. Taniguchi, S. Yasutaka, R. Kominami, and H. Shinohara Proliferation and differentiation of rat anterior pituitary cells Anat. Embryol. (Berl.) 206 2002 1 11
57. R. van Amerongen, A.N. Bowman, and R. Nusse Developmental stage and time dictate the fate of Wnt/β-catenin-responsive stem cells in the mammary gland Cell Stem Cell 11 2012 387 400
58. L.G. van der Flier, and H. Clevers Stem cells, self-renewal, and differentiation in the intestinal epithelium Annu. Rev. Physiol. 71 2009 241 260
59. J.E. Visvader, and G.J. Lindeman Cancer stem cells: current status and evolving complexities Cell Stem Cell 10 2012 717 728
60. V. Vives, G. Alonso, A.C. Solal, D. Joubert, and C. Legraverend Visualization of S100B-positive neurons and glia in the central nervous system of EGFP transgenic mice J. Comp. Neurol. 457 2003 404 419
61. J. Wesche, K. Haglund, and E.M. Haugsten Fibroblast growth factors and their receptors in cancer Biochem. J. 437 2011 199 213
62. C.I. Wu, J.A. Hoffman, B.R. Shy, E.M. Ford, E. Fuchs, H. Nguyen, and B.J. Merrill Function of Wnt/β-catenin in counteracting Tcf3 repression through the Tcf3-β-catenin interaction Development 139 2012 2118 2129
63. R.L. Yauch, S.E. Gould, S.J. Scales, T. Tang, H. Tian, C.P. Ahn, D. Marshall, L. Fu, T. Januario, and D. Kallop A paracrine requirement for hedgehog signalling in cancer Nature 455 2008 406 410
64. S. Yoshida, T. Kato, H. Yako, T. Susa, L.Y. Cai, M. Osuna, K. Inoue, and Y. Kato Significant quantitative and qualitative transition in pituitary stem/progenitor cells occurs during the postnatal development of the rat anterior pituitary J. Neuroendocrinol. 23 2011 933 943
65. K.K. Youssef, A. Van Keymeulen, G. Lapouge, B. Beck, C. Michaux, Y. Achouri, P.A. Sotiropoulou, and C. Blanpain Identification of the cell lineage at the origin of basal cell carcinoma Nat. Cell Biol. 12 2010 299 305
66. L. Zhu, P. Gibson, D.S. Currle, Y. Tong, R.J. Richardson, I.T. Bayazitov, H. Poppleton, S. Zakharenko, D.W. Ellison, and R.J. Gilbertson Prominin 1 marks intestinal stem cells that are susceptible to neoplastic transformation Nature 457 2009 603 607